Laurenti MD - Search Results

1

Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis.

Jesus JA, Sousa IMO, da Silva TNF, Ferreira AF, Laurenti MD, Antonangelo L, Faria CS, da Costa PC, de Carvalho Ferreira D, Passero LFD. Jesus JA, et al. Among authors: laurenti md. Pharmaceutics. 2021 Jun 19;13(6):908. doi: 10.3390/pharmaceutics13060908. Pharmaceutics. 2021. PMID: 34205283 Free PMC article.

2

The effect of phospholipase A2 from Crotalus durissus collilineatus on Leishmania (Leishmania) amazonensis infection.

Passero LF, Laurenti MD, Tomokane TY, Corbett CE, Toyama MH. Passero LF, et al. Among authors: laurenti md. Parasitol Res. 2008 Apr;102(5):1025-33. doi: 10.1007/s00436-007-0871-6. Epub 2008 Jan 8. Parasitol Res. 2008. PMID: 18180953

3

Ex vivo and in vivo biological behavior of Leishmania (Viannia) shawi.

Passero LF, Sacomori JV, Tomokane TY, Corbett CE, da Silveira FT, Laurenti MD. Passero LF, et al. Among authors: laurenti md. Parasitol Res. 2009 Nov;105(6):1741-7. doi: 10.1007/s00436-009-1614-7. Epub 2009 Sep 16. Parasitol Res. 2009. PMID: 19756748

4

Histopathology, humoral and cellular immune response in the murine model of Leishmania (Viannia) shawi.

Passero LF, Marques C, Vale-Gato I, Corbett CE, Laurenti MD, Santos-Gomes G. Passero LF, et al. Among authors: laurenti md. Parasitol Int. 2010 Jun;59(2):159-65. doi: 10.1016/j.parint.2009.12.010. Epub 2010 Jan 6. Parasitol Int. 2010. PMID: 20060062

5

Exacerbation of Leishmania (Viannia) shawi infection in BALB/c mice after immunization with soluble antigen from amastigote forms.

Passero LF, Da Costa Bordon ML, De Carvalho AK, Martins LM, Corbett CE, Laurenti MD. Passero LF, et al. Among authors: laurenti md. APMIS. 2010 Dec;118(12):973-81. doi: 10.1111/j.1600-0463.2010.02679.x. Epub 2010 Sep 14. APMIS. 2010. PMID: 21091779

6

Analysis of the protective potential of antigens released by Leishmania (Viannia) shawi promastigotes.

Passero LF, Marques C, Vale-Gato I, Corbett CE, Laurenti MD, Santos-Gomes G. Passero LF, et al. Among authors: laurenti md. Arch Dermatol Res. 2012 Jan;304(1):47-55. doi: 10.1007/s00403-011-1171-7. Epub 2011 Sep 1. Arch Dermatol Res. 2012. PMID: 21882046

7

Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.

Passero LF, Carvalho AK, Bordon ML, Bonfim-Melo A, Toyama MH, Corbett CE, Laurenti MD. Passero LF, et al. Among authors: laurenti md. Inflamm Res. 2012 Mar;61(3):255-63. doi: 10.1007/s00011-011-0407-5. Epub 2011 Dec 14. Inflamm Res. 2012. PMID: 22166919

8

Plants used in traditional medicine: extracts and secondary metabolites exhibiting antileishmanial activity.

Passero LF, Laurenti MD, Santos-Gomes G, Soares Campos BL, Sartorelli P, Lago JH. Passero LF, et al. Among authors: laurenti md. Curr Clin Pharmacol. 2014;9(3):187-204. doi: 10.2174/1574884709999140606161413. Curr Clin Pharmacol. 2014. PMID: 23173968 Review.

9

Dynamic of the cellular immune response at the dermal site of Leishmania (L.) amazonensis and Leishmania (V.) braziliensis infection in Sapajus apella primate.

Laurenti MD, Passero LF, Tomokane TY, Francesquini Fde C, Rocha MC, Gomes CM, Corbett CE, Silveira FT. Laurenti MD, et al. Biomed Res Int. 2014;2014:134236. doi: 10.1155/2014/134236. Epub 2014 Aug 28. Biomed Res Int. 2014. PMID: 25309902 Free PMC article.

10

Antimicrobial activity of oleanolic and ursolic acids: an update.

Jesus JA, Lago JH, Laurenti MD, Yamamoto ES, Passero LF. Jesus JA, et al. Among authors: laurenti md. Evid Based Complement Alternat Med. 2015;2015:620472. doi: 10.1155/2015/620472. Epub 2015 Feb 22. Evid Based Complement Alternat Med. 2015. PMID: 25793002 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page